Klinische Studie

A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR)

NCT: NCT04647253 · ACTIVE_NOT_RECRUITING

NCT-IDNCT04647253

Medizinische Daten: StatusACTIVE_NOT_RECRUITING

Startdatum2021-05-11

SponsorBoston Scientific Corporation (INDUSTRY)

First posted2020-11-30

Last updated2026-09-18

Kurzzusammenfassung

AGENT IDE is a Prospective, Randomized (2:1), Multicenter Trial. The purpose of this study is to assess the safety and effectiveness of the Agent Paclitaxel Coated PTCA Balloon Catheter compared to balloon angioplasty (POBA) in patients with in-stent restenosis (ISR) of a previously treated lesion of up to 26 mm in length (by visual estimate) in a native coronary artery 2.0 mm to 4.0 mm in diameter.

Offizielle Quelle

Auf ClinicalTrials.gov ansehen →

Daten aus der ClinicalTrials.gov-API. Den aktuellsten Status finden Sie im offiziellen Eintrag.